查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1986746

移植市场：按产品、应用、最终用户和地区划分，2026-2034 年

Transplantation Market by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End User (Hospitals, Transplantation Centers, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2025年全球器官移植市场规模达187亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到360亿美元，2026年至2034年的复合年增长率（CAGR）为7.34%。该市场正经历显着增长，其驱动因素包括医疗技术的快速进步、慢性病患病率的上升、各国政府和非政府组织（NGO）加强推广器官捐赠、专业移植中心的扩张以及医疗政策和保险覆盖范围的改善。

移植市场分析

  • 市场成长与规模：受快速的技术进步、慢性病盛行率上升以及医疗保健政策改善的推动，市场呈现稳定成长态势。
  • 市场主要驱动因素：影响市场成长的主要因素包括医疗技术的快速进步、慢性疾病导致的器官衰竭率上升、移植中心的扩张、政府支持措施以及医疗政策的演变。
  • 主要市场趋势：主要市场趋势包括持续转型为个人化移植医学以及生物工程器官和组织的应用。此外，对新型免疫抑制剂和保存方案研发投入的增加也推动了市场成长。
  • 区域趋势：北美凭藉其先进的医疗保健体系、高移植率和健全的器官捐赠网络，引领市场发展。中东和非洲也呈现显着成长，这得益于医疗基础设施的改善和意识提升。
  • 竞争格局：该市场的特点是主要企业积极寻求策略性併购和合作，致力于拓展产品系列和全球影响力。此外，这些公司也集中投资于研发，用于配方、组织工程和器官保存技术的创新。
  • 挑战与机会：该市场面临许多挑战，包括器官捐赠者短缺、器官捐赠相关的伦理问题以及医疗资源取得方面的区域差异。然而，组织工程技术的进步以及旨在支持公平取得移植服务的政策制定，正为市场成长创造新的机会。

移植市场趋势

移植技术的快速发展

外科技术、免疫抑制剂和器官保存技术的不断进步和创新，提高了移植成功率和患者预后，为市场成长创造了积极的前景。同时，微创手术技术的进步缩短了恢復时间，减少了併发症，从而提高了器官移植的可行性和普及度，也对市场成长产生了积极影响。此外，组织配型和相容性评估技术的快速发展，最大限度地降低了器官排斥的风险，也推动了市场成长。此外，将数位技术和人工智慧（AI）技术应用于移植领域，旨在实现更准确、更快速的器官相容性评估、患者预后预测和移植后护理管理，也促进了市场成长。

慢性疾病和器官衰竭的盛行率增加

糖尿病、高血压和心臟病等慢性疾病的日益普遍导致器官移植需求增加，成为市场成长的主要驱动力。反过来，糖尿病和高血压导致的肾衰竭发生率上升，进而推高了全球肾臟移植需求，进一步促进了市场成长。此外，心臟和肝臟疾病诊断数量的增加，以及由此导致的心臟和肝臟移植需求的增长，也推动了市场成长。此外，老年人口的成长，尤其是老年人更容易患上导致器官衰竭的慢性疾病，也为市场带来了良好的前景。而且，人们对各种健康状况的认识不断提高，诊断技术的进步，使得早期发现需要移植的患者变得更加容易，从而进一步促进了市场成长。

各国政府及非政府组织加强推广器官捐赠

各国政府和非政府组织（NGO）日益增强的器官捐赠推广影响力正积极推动市场成长。这促使公众意识宣传活动不断加强，捐赠流程日益简化，相关立法也得到完善，从而提高了器官捐赠者的数量，进而推动了市场成长。此外，政府和非政府组织与医疗机构加强合作，简化器官捐赠流程，也促进了市场成长。同时，将家属同意纳入捐赠流程的政策出台以及全国性捐赠者登记系统的建立，也推动了市场成长。最后，加强国际合作，共用器官捐赠的最佳实践和资源，并强化全球移植网络，也为市场成长提供了支持。

移植中心和服务扩展

全球范围内专业移植中心和服务数量的不断增长和规模的扩大正在推动市场成长。这些专业中心配备了先进的设施和技术精湛的专业人员，能够进行复杂的移植手术。因此，为了满足日益增长的治疗需求并扩大移植服务的覆盖范围，这些中心的建立正在推动市场成长。此外，专注于专业移植和个人化护理的中心，提供包括移植前咨询、先进手术以及移植后后续观察和復健在内的综合服务，也在促进市场成长。同时，中心向农村和医疗资源匮乏地区的扩张，使更多人能够获得移植服务，进一步推动了市场成长。

医疗保单和保险范围扩大

政府推出的各项医疗政策，例如财政援助、报销计划和保险覆盖范围，为器官移植手术提供支持，显着促进了市场成长。此外，加强不同医疗体系间移植手术流程和费用的标准化工作也推动了市场成长。同时，涵盖长期术后照护费用的医疗服务（例如免疫抑制剂治疗和定期监测排斥征兆及併发症）的整合也促进了市场成长。此外，政策制定者日益关注器官移植服务的公平性，致力于解决不同社会经济群体、种族和地区间移植率的差异，也推动了市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球移植市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 组织製品
  • 免疫抑制剂
  • 防腐液

第七章 市场区隔：依应用领域划分

  • 器官移植
  • 组织移植

第八章 市场区隔：依最终用户划分

  • 医院
  • 移植中心
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：促进因素、阻碍因素和机会

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • 21st Century Medicine
    • AbbVie Inc.
    • Arthrex Inc.
    • Astellas Pharma Inc.
    • BioLife Solutions Inc.
    • CareDx Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • TransMedics Inc.
    • Veloxis Pharmaceutical Inc.（Asahi Kasei Corporation）
Product Code: SR112026A7197

The global transplantation market size reached USD 18.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 36.0 Billion by 2034, exhibiting a growth rate (CAGR) of 7.34% during 2026-2034. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

  • Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.
  • Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.
  • Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.
  • Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.
  • Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.
  • Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends :

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

Breakup by Product:

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Tissue products account for the majority of the market share

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

  • Organ Transplantation
  • Tissue Transplantation

Tissue transplantation holds the largest share in the industry

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

  • Hospitals
  • Transplantation Centers
  • Others

Hospitals represent the leading market segment

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • 21st Century Medicine
  • AbbVie Inc.
  • Arthrex Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • CareDx Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • TransMedics Inc.
  • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Key Questions Answered in This Report

  • 1.How big is the global transplantation market?
  • 2.What is the expected growth rate of the global transplantation market during 2026-2034?
  • 3.What are the key factors driving the global transplantation market?
  • 4.What has been the impact of COVID-19 on the global transplantation market?
  • 5.What is the breakup of the global transplantation market based on the product?
  • 6.What is the breakup of the global transplantation market based on the application?
  • 7.What is the breakup of the global transplantation market based on the end user?
  • 8.What are the key regions in the global transplantation market?
  • 9.Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transplantation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Tissue Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressive Drugs
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Preservation Solution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Organ Transplantation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Transplantation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Transplantation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 21st Century Medicine
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Arthrex Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 BioLife Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 CareDx Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 TransMedics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Transplantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transplantation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Transplantation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Transplantation Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Transplantation Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Transplantation Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Transplantation Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Transplantation (Tissue Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Transplantation (Tissue Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Transplantation (Immunosuppressive Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Transplantation (Immunosuppressive Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Transplantation (Preservation Solution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Transplantation (Preservation Solution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Transplantation (Organ Transplantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Transplantation (Organ Transplantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Transplantation (Tissue Transplantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Transplantation (Tissue Transplantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Transplantation (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Transplantation (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Transplantation (Transplantation Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Transplantation (Transplantation Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Transplantation (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Transplantation (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Transplantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Transplantation Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Transplantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Transplantation Industry: Drivers, Restraints, and Opportunities
  • Figure 74: Global: Transplantation Industry: Value Chain Analysis
  • Figure 75: Global: Transplantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transplantation Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Transplantation Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Transplantation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Transplantation Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Transplantation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Transplantation Market: Competitive Structure
  • Table 7: Global: Transplantation Market: Key Players